Molecular therapy in pancreatic adenocarcinoma
- PMID: 15337483
- DOI: 10.1016/S1470-2045(04)01565-7
Molecular therapy in pancreatic adenocarcinoma
Abstract
Pancreatic cancer is one of the commonest causes of death from cancer. Despite therapy with surgery, conventional chemotherapy, and radiation, 5-year survival for patients with this diagnosis remains poor. However, advances in the molecular understanding of this malignant disease over the past 5 years might lead to new treatment strategies. Strategies of gene therapy, antiangiogenic treatments, immunotherapy, and signal-transduction inhibition are in preclinical development. This review presents an overview of molecular therapy in pancreatic cancer.
Similar articles
-
Current status of gene therapy for pancreatic cancer.Curr Surg. 2004 Jan-Feb;61(1):84-92. doi: 10.1016/j.cursur.2003.07.023. Curr Surg. 2004. PMID: 14972178 Review.
-
Novel targets for pancreatic cancer therapy.Surg Oncol Clin N Am. 2010 Apr;19(2):419-29. doi: 10.1016/j.soc.2009.11.012. Surg Oncol Clin N Am. 2010. PMID: 20159523
-
Pancreatic cancer: from molecular pathogenesis to targeted therapy.Cancer Metastasis Rev. 2008 Sep;27(3):495-522. doi: 10.1007/s10555-008-9134-y. Cancer Metastasis Rev. 2008. PMID: 18427734 Review.
-
Novel therapeutic approaches to advanced prostate cancer.Clin Adv Hematol Oncol. 2005 Apr;3(4):271-82. Clin Adv Hematol Oncol. 2005. PMID: 16167000 Review.
-
Adjuvant therapy for resectable pancreatic adenocarcinoma: review of the current treatment approaches and future directions.Cancer Treat Rev. 2014 Feb;40(1):78-85. doi: 10.1016/j.ctrv.2013.05.008. Epub 2013 Jun 26. Cancer Treat Rev. 2014. PMID: 23810287 Review.
Cited by
-
A novel pancreatropic coxsackievirus vector expressing glucagon-like peptide 1 reduces hyperglycemia in streptozotocin-treated mice.J Virol. 2011 Dec;85(23):12759-68. doi: 10.1128/JVI.00661-11. Epub 2011 Sep 21. J Virol. 2011. PMID: 21937637 Free PMC article.
-
Molecular targeted therapies for pancreatic cancer.Am J Surg. 2008 Sep;196(3):430-41. doi: 10.1016/j.amjsurg.2008.04.009. Am J Surg. 2008. PMID: 18718222 Free PMC article. Review.
-
Proton Pump Inhibitor Use is Associated With Risk of Pancreatic Cancer: A Nested Case-Control Study.Dose Response. 2018 Oct 1;16(4):1559325818803283. doi: 10.1177/1559325818803283. eCollection 2018 Oct-Dec. Dose Response. 2018. PMID: 30288155 Free PMC article.
-
Effect of NK4 transduction in bone marrow-derived mesenchymal stem cells on biological characteristics of pancreatic cancer cells.Int J Mol Sci. 2014 Mar 3;15(3):3729-45. doi: 10.3390/ijms15033729. Int J Mol Sci. 2014. PMID: 24595237 Free PMC article.
-
Role of α-gal epitope/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer.Cancer Sci. 2013 Mar;104(3):282-90. doi: 10.1111/cas.12084. Epub 2013 Feb 6. Cancer Sci. 2013. PMID: 23240661 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous